C. BunnagP. VipulakomP. PachareeC. SiriyanandaMahidol University2018-04-302018-04-301980-01-01Annals of Allergy. Vol.44, No.2 (1980), 100-105000347382-s2.0-0018844326https://repository.li.mahidol.ac.th/handle/20.500.14594/11159Forty-eight perennial rhinitis patients completed a six weeks' open trial of intranasal beclomethasone dipropionate aerosol. Each received a daily dose of 400 micrograms. Thirty-five responded excellently, seven reported satisfactory improvement and six failed. This study indicated that patients with a demonstrable allergic component responded favorably. However, due to the wide margin of safety the authors suggest that it be tried in non-infective perennial rhinitis with no demonstrable allergic component as well.Mahidol UniversityMedicineArticleSCOPUS